Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis

Pulmonary hypertension is a poor prognostic factor in patients with interstitial lung disease. No established treatment exists for pulmonary hypertension secondary to interstitial pneumonia. We describe the case of an 81-year-old woman with idiopathic pulmonary fibrosis (IPF), who was admitted to ou...

Full description

Bibliographic Details

Published in:	Respiratory Medicine Case Reports
Main Authors:	Naomi Onda, Yosuke Tanaka, Mitsunori Hino, Akihiko Gemma
Format:	Article
Language:	English
Published:	Elsevier 2015-01-01
Subjects:	Bosentan Endothelin antagonist Idiopathic pulmonary fibrosis Pulmonary hypertension Respiratory failure
Online Access:	http://www.sciencedirect.com/science/article/pii/S2213007114000586